glp-1 weight regain In recent years, medications have transformed obesity treatment, producing unprecedented amounts of loss in clinical trials. But they come with an important challenge... What happens when people stop taking them? Those discontinuing GLP-1 medications rapidly

A meta-analysis of inositol for depression and anxiety disorders

The effects tend to be modest, and the research is often limited in size or quality

You can report suspected side effects directly to the MHRA through the Yellow Card scheme at yellowcard.mhra.gov.uk or via the Yellow Card app, contributing to ongoing medication safety surveillance

Since the mechanisms associated with the risk of suicide may differ in the episodes presented

doi: 10.3390/ijms22179459 107 ZulloAHassanCCristofariFAndrianiADe FrancescoVIerardiEet al

While off-label use of medication isnt uncommon, insurance typically wont cover the cost of semaglutide in these cases